Biosurfactant complexed with arginine has antibiofilm activity against methicillin-resistant Staphylococcus aureus

Future Microbiol. 2024;19(8):667-679. doi: 10.2217/fmb-2023-0271. Epub 2024 Jun 12.

Abstract

Aim: The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant Staphylococcus aureus (MRSA). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. Result: RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. Conclusion: RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant S. aureus biofilms.

Keywords: MRSA; Staphylococcus aureus; biofilms; medical catheter; surfactants.

Plain language summary

[Box: see text].

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Arginine* / chemistry
  • Arginine* / pharmacology
  • Biofilms* / drug effects
  • Biofilms* / growth & development
  • Drug Synergism
  • Glycolipids / chemistry
  • Glycolipids / pharmacology
  • Humans
  • Methicillin-Resistant Staphylococcus aureus* / drug effects
  • Microbial Sensitivity Tests*
  • Oxacillin / pharmacology
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control
  • Surface-Active Agents* / chemistry
  • Surface-Active Agents* / pharmacology

Substances

  • Arginine
  • Anti-Bacterial Agents
  • Surface-Active Agents
  • Glycolipids
  • rhamnolipid
  • Oxacillin